✦ LIBER ✦

Dendritic cells become BCR–ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib

✍ Scribed by Wang, L; Butt, N M; Atherton, M G; Clark, R E

Book ID: 110055868
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 82 KB
Volume: 18
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403342

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination with autologous non-irradiat

Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia

✍ Jörg Westermann; Joachim Kopp; Antje Van Lessen; Ann-Christine Hecker; Gökben Ba 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

RQ-PCR based WT1 expression in compariso

RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia

✍ Susanne Schnittger; Ulrike Bacher; Wolfgang Kern; Claudia Tschulik; Tamara Weiss 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Frequency and clinical significance of B

Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

✍ Jabbour, E; Kantarjian, H; Jones, D; Talpaz, M; Bekele, N; O'Brien, S; Zhou, X; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

T cell recognition of bcr/abl in healthy

T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemia

✍ Jörg Westermann; Claudia Schlimper; Günther Richter; Johannes Mohm; Bernd Dörken 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Identification of a rare e8a2 BCR-ABL fu

Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib

✍ Cayuela, J M; Rousselot, P; Nicolini, F; Espinouse, D; Ollagnier, C; Bui-Thi, M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Molecular response to imatinib in patien

Molecular response to imatinib in patient with Ph negative p190 BCR–ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis

✍ M. Radojkovic; S. Ristic; S. Pavlovic; M. Colovic 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB

An atypical case of Philadelphia (Ph) negative, e1a2 BCR-ABL transcript positive chronic myeloid leukemia (CML) characterized with cyclic periodic leukocytosis and spontaneous remissions is reported. The patient was treated with imatinib and good hematology response with molecular remission was achi